Why the study?
Can physicians accurately predict serum lidocaine levels in patients receiving intravenous lidocaine in a coronary care unit?
Can physicians accurately predict serum lidocaine levels in patients receiving intravenous lidocaine in a coronary care unit?
Answers are grounded in this paper and cite their sources.
Clinical judgment alone may be insufficient for accurately predicting serum lidocaine levels in CCU patients, highlighting the need for objective laboratory testing.
Clinical judgment is highly vulnerable to exposes. It can be exposed as a fraud by an autopsy that refutes the antemortem diagnosis or discloses a missed diagnosis of a potentially curable disease. Less catastrophic, but embarrassing nevertheless, the expose can come during life when laboratory data are similarly in conflict with a clinical assessment. Elsewhere in this issue (p 571) Deglin and associates report on such an embarrassment. Having determined serum lidocaine concentrations in 84 samples obtained from 33 patients receiving intravenous lidocaine hydrochloride infusions in a coronary care unit, these investigators proceeded to correlate the determined values in each patient with those predicted by his physician. Specifically, the physician was asked whether the serum lidocaine levels would be within, below, or above the therapeutic range and, when the predicted level was above this range, whether it would be in the toxic range. In 49% of these samples, the predictions
No takes yet. Share an insight, caveat, or question.
S. Vaisrub (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: